Several Pharmacy Colleges in Maha Cut Short DPharm Course to 5 Months Amid PCI Approval Delays
Pune: The first-year Diploma in Pharmacy (DPharm) programme has been reduced to a five-month session this year after the Pharmacy Council of India (PCI) delayed approvals for several colleges. This delay has forced institutions to compress what is typically a 10 to 11-month academic schedule into a shorter and more intensive format. As per the Maharashtra State Board of Technical Education (MSBTE), the first-year academic session will now be conducted from October 2025 to April 18, 2026, with annual examinations beginning on April 30, 2026. The revised calendar has sparked concerns among educators and students about managing the full syllabus within such a limited timeframe. To streamline the schedule, the board has mandated three internal examinations—from December 15 to 19, February 9 to 14, and April 6 to 10—followed by practice exams between April 20 and 25. However, with minimal breaks and a packed curriculum, students are expected to cope with a far more demanding academic load than usual. Faculty members have voiced apprehensions over the possible impact on teaching quality and practical training. According to a recent media report by theHindustan Times, several colleges have started adopting crash-course formats and extended hours to ensure students can complete the syllabus before final exams.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!